VAPOR 2 trial data on water vapor ablation for localized prostate cancer now published

Published VAPOR 2 trial data evaluate water vapor ablation for localized prostate cancer; the procedure may offer a minimally invasive option, but specific outcomes and numbers are not reported in this news source.

• Design, sample size, and primary results not provided in source snippet.
• No secondary outcomes or complications reported.
• Limitation: News summary without access to original study details; interpretation caution advised.

RadPigeon summaries are original and for information only. They are not clinical advice.